![]() |
市场调查报告书
商品编码
1378014
葡萄糖酸钙市场:2023-2028 年预测Calcium Gluconate Market - Forecasts from 2023 to 2028 |
葡萄糖酸钙是一种用石灰或碳酸钙中和葡萄糖酸製成的矿物质补充剂。葡萄糖酸钙可用于治疗低钙手足抽搐、低血压、副甲状腺功能亢进引起的副甲状腺机能亢进症、快速生长或怀孕引起的低血钙、高镁血症等,采用静脉疗法等,有助于于治疗因缺乏钙引起的疾病。由于药品、食品和饮料等最终用途产品的需求不断增加,葡萄糖酸钙市场预计将在全球扩张。
参与企业在葡萄糖酸钙市场的投资将致力于获取新技术、获取原材料、有效的采购和库存管理、改进产品系列以及即使在困难的经济状况下也能利用技能来维持成长。由于不同市场和国家的经济和社会障碍差异很大,葡萄糖酸钙製造商和相关企业正在专注于制定针对特定国家的策略。
乳酸葡萄糖酸钙是一种白色结晶质粉末,无味、无臭。它具有生理相容性且无毒性。葡萄糖酸乳酸钙具有优异的生物利用度、中性味道、良好的溶解度。在医学上,它被用作高级钙源。对人体研究的科学分析表明,乳酸葡萄糖酸钙始终比其他钙盐更显着地增加骨骼密度。乳酸钙主要用于低温食品加工、生产线混合以及溶解度敏感问题的其他应用,例如透明饮料和浓缩/快速製剂。这些是葡萄糖酸钙市场的主要驱动因素。
按应用细分葡萄糖酸钙市场,製药业占最大份额。由于生活方式的改变和缺乏锻炼,对骨质疏鬆症药物的需求增加正在推动市场。推动葡萄糖酸钙市场的另一个因素是由于繁忙的工作日程而对冷冻和去皮蔬菜的需求不断增长。消费者对预防缺钙产品的需求显着增加,推动了葡萄糖酸钙市场的发展。
北美地区医疗保健产业的扩张是该地区葡萄糖酸钙市场的主要驱动因素。治疗甲状腺疾病和佝偻病的药物生产以及强生和辉瑞等多家製造商在该地区的存在是推动葡萄糖酸钙市场成长的因素。由于该地区食品和饮料行业的扩张,预计亚太地区在预测期内将以最高的成长率发展。由于健康意识的提高,对生产营养丰富的食品的需求不断增加,预计该地区的葡萄糖酸钙市场将会成长。
我们于 2021 年 4 月与儿童投资基金基金会、纽约科学院营养科学计画合作推出了钙任务小组。该计划的主要目标是解决全球缺钙及其对健康的影响、钙状态指标以及孕产妇供给以改善怀孕结果。经常建议供给钙,例如葡萄糖酸钙,以维持心血管健康。这是因为研究表明,钙水平较低与心血管疾病风险增加之间存在潜在关联。由于心臟病死亡人数不断增加,葡萄糖酸钙的市场占有率将会增加。
Calcium gluconate is a mineral supplement that can be made by neutralizing gluconic acid with lime or calcium carbonate. Using intravenous therapy (IV) and other ways, calcium gluconate aids in the treatment of illnesses brought on by calcium shortages, such as hypocalcemia tetany, hypotension, hypocalcemia linked to hyperparathyroidism, hypocalcemia brought on by fast growth or pregnancy, and hypermagnesemia. The calcium gluconate market is expected to expand globally due to rising demand for end-use products, including medicines, and food & beverages.
Investments made by participants in the calcium gluconate market will go towards acquiring new technologies, obtaining raw materials, effective procurement and inventory management, improving product portfolios, and using skills to sustain growth in difficult economic times. Manufacturers of calcium gluconate and related firms are concentrating on developing country-specific strategies since the economic and social obstacles vary greatly between various markets and nations.
Calcium lactate gluconate is a powder that is white, crystalline, tasteless, and odorless. It has high physiological compatibility and is non-toxic. Calcium lactate gluconate has excellent bioavailability, a neutral taste, and excellent solubility. In medicines, it serves as a premium calcium source. According to scientific analyses of human research, calcium lactate gluconate increases bone mineral density more consistently and significantly than other calcium salts. It is mostly used in food processing at low temperatures, in line blending, and other applications where solubility is a delicate issue, such as clear drinks and concentrated or quick preparations. This is the main driving factor for the calcium gluconate market.
The pharmaceutical industry accounted for the largest share of the calcium gluconate market when segmented by application due to its advantages in medical treatment. The increased demand for osteoporosis medicines is driving the market due to the changing lifestyle and inactivity. Another factor driving the calcium gluconate market is the rising demand for frozen and peeled veggies due to hectic work schedules. There has been a significant rise in consumer demand for calcium deficiency prevention products, propelling the calcium gluconate market.
Expanding the local healthcare sector in North America is the main driver for the calcium gluconate market in the region. The production of medications for treating thyroid problems and rickets, as well as the presence of multiple manufacturers in the area, including Johnson & Johnson and Pfizer Inc., are factors propelling the calcium gluconate market growth. While due to the expanding regional food & beverage sector, Asia-Pacific is anticipated to develop at the greatest growth rate throughout the projection period. As the demand for the manufacturing of nutrient-dense foods increases with growing health awareness, the calcium gluconate market is anticipated to rise in the region.
In collaboration with the Children's Investment Fund Foundation, the Nutrition Science Programme of the New York Academy of Sciences, they launched a calcium task group in April 2021. This program's major objective was to address worldwide calcium shortage and its effects on health, calcium status indicators, and calcium supplementation for expectant mothers to enhance pregnancy outcomes. Calcium supplementation, such as calcium gluconate, is frequently advised to maintain cardiovascular health since studies have revealed a potential relationship between low calcium levels and an increased risk of cardiovascular disorders. The calcium gluconate market share will increase due to the rise in heart disease fatalities.